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An unusual intermediate bound to  the enzyme was 
detected in the interaction of thiosemicarbazide with 
sheep  liver  serine hydroxymethyltransferase. This  in- 
termediate had absorbance maxima at 464 and 440 
nm. Such spectra are characteristic of resonance sta- 
bilized intermediates detected in the interaction of sub- 
strates and quasisubstrates with pyridoxal phosphate 
enzymes. An intermediate of this kind has not been 
detected in the interaction of thiosemicarbazide with 
other pyridoxal phosphate enzymes. This intermediate 
was generated slowly (tH = 4 min) following  the addi- 
tion of thiosemicarbazide (200 MM) to sheep liver  serine 
hydroxymethyltransferase (5 MM). It was bound to  the 
enzyme  as evidenced by circular dichroic bands at 464 
and 440 nm and the inability to be removed upon 
Centricon filtration. The kinetics of interaction re- 
vealed that thiosemicarbazide was a slow binding re- 
versible inhibitor in this phase with a k,, of 11 M“ s” 
and a korf of 5 X s-’. The intermediate was con- 
verted  very  slowly (k = 4 X s-’) to the final 
products, namely the apoenzyme and the thiosemicar- 
bazone of pyridoxal phosphate. A minimal kinetic 
mechanism involving  the  initial conversion to the  in- 
termediate absorbing at longer wavelengths and the 
conversion of this intermediate to  the  final product, as 
well as, the formation of pyridoxal phosphate-thio- 
semicarbazone directly by an alternate pathway is 
proposed. 
Serine hydroxymethyltransferase (SHMT, EC 2.1.2.1)’ a 
pyridoxal 5”phosphate (PLP) protein, catalyzes the first step 
in  the pathway for the interconversion of folate coenzymes. 
SHMT facilitates the formation of 5,lO-methylenetetrahydro- 
folate from serine and tetrahydrofolate  (H4-folate) as well as 
the aldolytic cleavage of a number of P-hydroxyamino acids, 
decarboxylation of aminomalonate, and  transamination of D- 
alanine in addition to  other reactions  (Schirch, 1984; Ulevitch 
and Kallen, 1977; Palekar et al., 1973; Mathews and Drum- 
mond, 1990). It is also a component of the thymidylate  syn- 
thesis cycle (Snell, 1984) along with dihydrofolate reductase 
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and thymidylate synthase which have been favorite target 
enzymes for the design of chemotherapeutic agents. Attempts 
at  developing inhibitors specific to SHMT have not been 
successful (Tendler et al., 1989). The systematic  examination 
of the interaction of various carbonyl-directed reagents with 
SHMT appeared promising for the design of specific inhibi- 
tors for this enzyme. This  has been our approach  in the study 
of interaction of aminooxy compounds with SHMT  (Manohar 
et al., 1984; Baskaran et al., 1989a, 1989b; Appaji Rao, 1991; 
Acharya et al., 1991). We had demonstrated that 0-amino-D- 
serine and aminooxyacetic acid, which could be considered as 
aminooxy analogues of serine and glycine,  were potent inhib- 
itors of the enzyme and generated a unique intermediate  in 
their reaction with SHMT. 
Hydrazides are extensively used as inhibitors of PLP  en- 
zymes and  to probe into  the interactions at  the active site of 
these enzymes (Sizer and Jenkins, 1963; Torchinsky and 
Koreneva, 1964;  Wood and Abrahams, 1971;  Wood and Pees- 
ker, 1974; Fisher and Davies 1974; Klosterman, 1986). It was 
therefore of interest to examine the mechanism of reaction of 
hydrazide derivatives with sheep liver SHMT.  In  this paper 
we describe the slow binding of thiosemicarbazide with SHMT 
resulting  in the formation of a hitherto undetected enzyme- 
bound intermediate, characterized by absorption maxima at 
464 and 440 nm. This intermediate was converted to  the  PLP- 
thiosemicarbazone extremely slowly, indicating the potential 
of these  reactions  in the design of more effective and specific 
inhibitors for SHMT. 
EXPERIMENTAL  PROCEDURES 
Materiak 
The following biochemicals were obtained from Sigma. 2-Mercap- 
toetbanol, PLP, Na-acetyl-L-lysine, EDTA. Centricon-30 were ob- 
tained from Amicon Division, W. R.Grace and Co., Danvers, MA. L- 
[3-14C]Serine (53  mCi/mmol) was purchased from Amersham Inter- 
national, Bucks, England. HI-folate was prepared by the method 
previously described (Hatefi et al., 1959). Thiosemicarbazide was 
obtained from E. Merck Darmstadt, Germany. 
Methods 
scribed by Baskaran  et al. (1989a). The enzyme (100 mg)  was dialyzed 
Enzyme  Purification and Assay-The enzyme was purified as  de- 
for 24 h  against l liter of 0.05 M potassium  phosphate buffer,  pH 7.4, 
containing 1 m M  EDTA  and 1 mM 2-mercaptoethanol (buffer A) with 
four changes to remove free PLP.  The enzyme activity was assayed 
by the procedure of Taylor and Weissbach (1965) as modified by 
Manohar et al. (1982). The specific activity of the enzyme ranged 
from 7 to 9 rmol of HCHO formed per min per mg of protein. 
Spectral Measurements-All the spectral  measurements were car- 
ried out using buffer A at  25 * 1 “C, unless otherwise mentioned. 
Absorption spectra were recorded in a Shimadzu UV 240 double- 
beam  spectrophotometer. Circular dichroism (CD) measurements 
were carried out  in a Jasco J 20C spectropolarimeter equipped with a 
DP-500 N data processor and monitor scope UP 3830 A. The  instru- 
ment was continuously purged with pure  nitrogen before and during 
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the experiments.  Slits were programmed to lo-A bandwidth.  The  CD 
spectra were plotted  as molar  ellipticity in  the visible and  as  mean 
residue ellipticity in the far UV region (Greenfield and Fasman, 
1969). 
Preparation of PLP-Thiosemicarbazone-The enzyme (25 FM) was 
mixed  with TSC (2 mM), incubated at 25 "C for 2  h, and  heated at 
90 "C for 2  min. The  precipitated  protein was  removed by centrifu- 
gation a t  20,000 X g. The  supernatant  (25  rl) was used  for  identifying 
the thiosemicarbazone. The  PLP-thiosemicarbazone was prepared by 
50 "C for 1 h (Furst  and Gustafson, 1967). 
reacting equal amounts of PLP  and thiosemicarbazide (10 mM) at 
HPLC of PLP-Thiosemicarbazone-The thiosemicarbazone ob- 
tained upon the  interaction of the enzyme  with TSC  and  in  nonen- 
zymatic model systems were processed separately  on a LKB  Spheri- 
sorb octyl 3-rm (4.6 X 100 mm) column using 0.1% trifluoroacetic 
acid in water (solvent A) and 50% acetonitrile (solvent B) as the 
solvent system. The  products were eluted with increasing  concentra- 
tions of 0.1% trifluoroacetic acid in 50% acetonitrile  (solvent B) as 
follows: 0-5 min, 0% solvent B; 5-15 min, 25% solvent B; 15-30 min, 
50% solvent B; 30-45 min, 100% solvent B. The flow rate was 0.5 
ml/min.  The column effluents were monitored a t  390 nm  in a Shi- 
madzu LC-6A HPLC system. 
Centricon Filtration-The  enzyme (5 p ~ )  was incubated  with  TSC 
(200 pM) for 90 min at  25 "C  in a 3-ml  Centricon  tube. An  enzyme 
sample similarly incubated  but  in  the  absence of TSC served as a 
control.  The  control (1 ml)  and  one  aliquot (1 ml) of the  test enzyme 
were then centrifuged a t  4,000 X g for 30 min.  A duplicate  set of the 
test sample was centrifuged in a standard  tube.  The  contents of the 
upper chamber of the Centricon set up were reconstituted to the 
original volume (1 ml).  The  spectra of the  reconstituted  portions,  the 
filtrates, and also of the centrifuged enzyme were recorded in a 
Shimadzu UV-240 spectrophotometer. 
RESULTS 
Inhibition of the Actiuity of Sheep Liver SHMT by TSC- 
The  time course of the  reaction,  initiated by the  addition of 
the enzyme (10 nM) to  solutions  containing  saturating  con- 
centrations of L-serine (3.6 mM) and H4-folate (2 mM) was 
linear  up  to 15 min  under  the  conditions of the assay. However 
in  the presence of varying concentrations of TSC (1-3 mM) 
i t  was not linear, and significantly higher inhibition was 
observed at  later  points  in  the  time course of the reaction 
(Fig. 1). Such inhibition could occur, among other reasons, 
due  to slow binding of the  inhibitor  to  the nzyme or mecha- 
nism-based  inactivation.  The  instability of the enzyme at  low 
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FIG. 1. Progress curves for the reaction of sheep liver 
SHMT in the presence of TSC. The  activity of the enzyme (10 
nM) was assayed in  the presence of increasing  concentration (0, 1, 2, 
and 3 mM) of TSC  at 37 "C in reaction mixtures containing 0.4 M 
phosphate buffer (pH 7.4), 1 mM EDTA, 1.8 mM dithiothreitol, 2 mM 
H4-folate,  and 3.6 mM ~-[3- '~C]serine (210,000  cpm/100 pl). Aliquots 
(100 pl) were withdrawn a t  various time intervals indicated, the 
reaction was arrested by the  addition of an equal volume of dimedone, 
and  the  product formed  was estimated  (Taylor  and Weissbach, 1965; 
Manohar  et al.,  1982). 
concentration (10 nM) precluded studying  the reaction until 
the  enzyme-inhibitor complex could reach  steady  state equi- 
librium. When  SHMT (1 p ~ )  was preincubated  with  increas- 
ing concentrations of TSC (0-300 p ~ )  (Fig. 2), the overall 
activity decreased as a function of time  and  TSC  concentra- 
tions.  The loss of activity followed a  biphasic mode of inhi- 
bition. The initial phase was linear up to 20 min and was 
dependent  upon  the  concentration of the  inhibitor used. This 
was followed by a slower phase which extended over long 
periods of time and terminated with almost total loss of 
enzyme  activity. These  results suggested that  there could be 
more than  one mode of interaction of the enzyme with  the 
inhibitor. 
TSC was a noncompetitive  inhibitor of SHMT  in  the  first 
phase of interaction when serine was the varied substrate 
(data  not  shown). A  replot of the slope of the reciprocal plot 
uersus concentration of TSC gave an  apparent Ki of 50 pM. 
Although such intersecting plots are often indicative of re- 
versible interactions between the inhibitor and an enzyme 
form, it could also arise by irreversible inactivation of the 
enzyme. Incubation of the enzyme (1 ptM) for 10 h at  25 "c 
with  TSC (300 p ~ )  resulted  in  almost complete (95%) loss of 
activity, while the enzyme  similarly treated  but  in  the absence 
of TSC lost little activity. Incubation of the  inhibited enzyme 
(1 p M )  with PLP (500 pM) for 5 min, restored 48% of the 
activity compared to the control enzyme, which was also 
similarly incubated with PLP (500 p ~ )  for 5 min. The enzyme 
(1 p M )  incubated  with  TSC (300 p M )  for 20 min had 14% of 
residual activity  and  upon  preincubation of this enzyme (1 
p M )  with PLP (500 p ~ )  for 5 min regained  only 24% of the 
activity  as  the  control  (Table I).This paradoxical observation 
suggested that, upon incubation for longer periods, the en- 
zyme-inhibitor complex changed  to a  form which was readily 
reconstituted by PLP to the active enzyme. These results 
implied that  there were multiple steps  in  the  interaction of 
SHMT with TSC. The presence of PLP  at   the active site 
with its characteristic spectral properties enabled further 
examination of the  interaction between the enzyme and  TSC. 
Spectral Studies-The sheep liver SHMT  has  an  absorb- 
ance maximum at 425 nm due to  an  internal aldimine (Ma- 
nohar  et ul., 1982). The addition of 200 p~ of TSC  to  the 
enzyme (5 pM)  resulted in a red shift of the absorbance 
maximum at 425 nm,  an increased absorbance at  464, 440, 
390, and 320 nm. After 15 min,  the  spectra  had clear  maxima 
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FIG. 2. Time- and concentration-dependent inhibition of 
SHMT by TSC. The enzyme (1 p ~ )  in buffer A was separately 
preincubated with 50, 100, 200, and 300 PM of TSC. Aliquots (10  pl) 
were withdrawn a t  time intervals indicated into the assay mixture 
containing 0.4 M phosphate buffer (pH 7.4), 1 mM EDTA, 1.8 mM 
dithiothreitol, 2 mM H4-folate, and 3.6 mM ~-[3- '~C]serine (72,000 
cpm)  and  incubated for 2 min at  37 "C. The  amount of HCHO formed 
was determined  (Taylor  and Weissbach, 1965; Manohar et al., 1982). 
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TABLE I 
Time-dependent  inhibition of sheep liuer SHMT by TSC and 
reactivation  by PLP 
The enzyme (1 p ~ )  in buffer  A was incubated a t  25 "C with TSC 
(300 p ~ ) .  Aliquots were withdrawn a t  time points indicated and 
incubated for 5 min at  25 "C  in buffer  A either with 500 p~ PLP or 
without it. Enzyme (1 p M ) ,  similarly treated but in the absence of 
TSC, served as  control. A portion (10 pl) of this was then  assayed for 
activity.  The activity of the  control enzyme (1 p ~ )  a t  10  h was more 
than 97% of its activity at, 0 time. 
Time 
Activity  remaining 
Without PLP With PLP 
% h 
0.3 14 24 
1.5  14 32 
3.0 11 34 
6.0 6 47 
10.0 5 48 
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FIG. 3.  Visible absorbance spectra of sheep liver SHMT 
upon its interaction with TSC. The enzyme (5 p ~ )  (continuous 
line) in buffer A was mixed with TSC (200 p ~ ) ,  and  the  spectrum 
was recorded 15 s after  the  addition of the  inhibitor  and every minute 
thereafter for 15 min (discontinuous  lines). 
at 464,440,390,  and 320 nm (Fig. 3). During  the  next 15 min, 
there was no appreciable change a t  464- and 440-nm spectral 
peaks, whereas there was a slow increase in absorbance a t  
390- and 320-nm  peaks. Thereafter,  there was a slow decrease 
in absorbance at  464 and 440 nm  and a continued  increase  in 
absorbance at  390 and 320 nm (Fig.  4). The  spectral  change 
in  this  instance  had a clear  isosbestic point  at 411 nm.  This 
phase of interaction was very slow, and  the conversion was 
not complete  even after 24 h. At these periods of time,  there 
was no discernible change  in  the  spectral  properties of the 
native enzyme. Upon the addition of TSC (200 p ~ )  to  the 
enzyme ( 5  p ~ ) ,  there was no appreciable change  in  the  ab- 
sorbance between 250-300 nm except  for  a slight (10%) in- 
crease in absorbance at 278 nm (data not shown). It was, 
therefore, of interest to monitor whether the intermediate 
represented a form bound to the enzyme and, if so, the 
strength of its binding. 
The  characteristic  CD  spectrum of the holoenzyme with a 
maximum at 430 nm provided a convenient  method  to ex- 
amine  the possibility of the  intermediate being bound  to  the 
active  site of the enzyme. Upon the  addition of TSC (400 p ~ )  
t o  sheep liver SHMT (5 p ~ ) ,  the CD spectrum was altered, 
forming a new spectrum  with positive  dichroic  maxima at  464 
and 440 nm (Fig. 5) corresponding  to  the  absorbance  peaks 
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FIG. 4. Visible absorbance spectrum of sheep liver SHMT 
during the second phase of its interaction with TSC. The 
enzyme (5 p ~ )  in buffer  A  was  mixed  with TSC (200 p ~ )  as described 
in Fig. 3. The absorbance spectrum was recorded 30 min after the 
incubation  and every  3 min for  90 min  thereafter. 
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FIG. 5. Changes in the visible circular dichroic spectrum of 
sheep liver SHMT  upon its interaction with TSC. The enzyme 
(5 p ~ )  in buffer A ( 1 )  and TSC (200 p ~ )  were mixed, and the 
spectrum was  recorded 50 min ( 2 )  and 24 h ( 3 )  after  the  addition of 
TSC to the enzyme. The spectrum were reconstructed for molar 
ellipticity  according to  the  method of Greenfield and  Fasman (1969). 
seen  in Fig. 4. The CD spectrum recorded 45 min  after  the 
addition of TSC showed peaks at  these wavelengths. Subse- 
quently,  the  intensity of these  bands decreased  very slowly, 
and a spectrum recorded 24 h later  retained  about 25% of the 
maximal  absorbance of the  peaks (Fig. 5).  These  observations 
suggested that  the  intermediate was probably still bound to 
the enzyme. The  far  ultra-violet CD spectrum of the enzyme 
was not  altered appreciably in  the presence of TSC suggesting 
that  TSC was not probably causing a gross change in the 
protein  (data  not  shown). 
Separation of Products by Centricon Filtration-As the  in- 
termediates formed on  the  addition of TSC  to  SHMT were 
stable,  it was thought worthwhile to  separate  them  from  the 
enzyme and also determine if they were loosely or tightly 
bound  to  the enzyme. The enzyme ( 5  p ~ )  was incubated at  
25 "C for 90 min, transferred to a Centricon-30 tube, and 
centrifuged a t  4000 X g for 30 min.  The  retentate was recon- 
stituted to the original (1 ml) volume. The spectra of the 
filtrate  and  the  retentate were recorded. The  filtrate  had  no 
clear spectra (Fig. 6, curve 1 ), whereas the  retentate gave the 
characteristic  spectrum of SHMT absorbing maximally at  425 
nm  (curve 2 ) .  The enzyme (5  p ~ )  was reacted  with  TSC (200 
Serine Hydroxymethyltransferase 19069 
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FIG. 6. Evidence for the generation of an enzyme-bound 
intermediate  when TSC was added to sheep liver SHMT. The 
enzyme (5 PM) in buffer A was incubated a t  25 "C for 90 min. It was 
then  transferred  onto a Centricon-30  tube  and centrifuged a t  4000 X 
g for 30 min. The  spectrum of the  filtrate ( I  ) and of the  retentate  in 
the upper chamber after reconstitution to the original volume (2) 
were recorded. The enzyme (5  PM) treated with TSC (200 PM) was 
similarly processed, and  the  spectra of the  filtrate ( 3 )  and  the  reten- 
tate ( 4 )  were recorded. The enzyme  was treated  exactly  as described 
with  TSC  but only centrifugation  instead of Centricon  treatment was 
carried  out  and  the  spectrum was recorded (5). 
p ~ )  for 90 min  and subjected to  Centricon  filtration as de- 
scribed above. The  filtrate  in  this  instance  had  spectrum  with 
absorbance maxima a t  390 and 320 nm  (curve 3 ) .  The  reten- 
tate  had a spectrum  with clear maxima at  464 and 440 nm, 
but  the  absorbance  at 390 and 320 nm  had decreased consid- 
erably  (curve 4 )  compared to  the  spectrum of the enzyme (5 
p ~ )  treated with TSC (200 PM) but centrifuged instead of 
Centricon  treatment (curve 5). These  experiments suggested 
that  the 464- and 440-nm absorbing species was probably  a 
tightly bound enzyme intermediate, which was stable for 
considerable  periods of time. 
Reuersibility and Dissociation of the  Inhibitor  from  the En- 
zyme-The results described  above  suggested that  TSC was 
probably a slow binding inhibitor forming an intermediate 
showing visible absorbance  maxima at 464 and 440 nm  and 
the r l z , f f  was probably very low. To  examine  this possibility, 
the enzyme (25 and 50 p ~ )  was incubated with varying 
concentrations of the  inhibitor for different periods of time. 
A time course of the  spectral  changes was continuously  mon- 
itored. After the  spectral species with  maximal  absorbance at  
464 and 440 nm were formed, aliquots were withdrawn  and 
diluted 50-, loo-, and 200-fold (data for the  last  concentration 
of the enzyme not given) in buffer A. These  dilutions were 
adequate since the calculated  second order  rate  constant  for 
the association was small.  Aliquots were assayed  for activity 
in  the  absence of PLP (Fig. 7 ) .  A zero order regain of activity 
was  noted,  and a first  order  rate of 5.0 x s-l was  calculated 
(Fig. 7 ,  inset).  The recovery of activity was not complete in 
the absence of PLP  and was dependent  on  the  concentration 
of the  inhibitor used. This was due  to  the existence of the 
second  step  in  the  interaction of TSC  with  SHMT where the 
intermediate was converted very slowly to  the apoenzyme. 
Identification of the  Product  Formed  in  the R action of TSC 
with Sheep Liver SHMT-The  spectral  properties of the  final 
product was compatible  with the suggestion that it was prob- 
ably a PLP-thiosemicarbazone. The following experiment 
confirmed the suggestion. The supernatant of the enzyme 
treated with TSC, obtained as described under "Methods" 
had a visible absorbance  spectrum at 390 and 320 nm.  When 
this was subjected to  reversed-phase  HPLC, a peak  appeared 
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FIG. 7. Reversal of the  initial phase of inhibition of sheep 
liver SHMT by TSC. The enzyme (25 (0) or 50 FM (0)) in 1 ml  of 
buffer A was  mixed with 100 (0) or 400 PM (0) of TSC.  Spectra were 
recorded. Aliquots were diluted (when the spectral species showed 
maximal  absorbance a t  440 and 464 nm) 50 (0)- or 100 (0)-fold  in 
buffer A. 10-pl aliquots of this were then assayed  for activity a t  time 
points  indicated,  after  dilution. Inset, In [100(1-u/u,)] plotted  against 
the  time of incubation  after  dilution. u = velocity a t  time t ,  u, = final 
velocity regained. The slope is equal to -&. 
with a retention  time of 21.6 min which  was identical  to  that 
obtained  with  an  authentic  sample of PLP-TSC (21.8 min). 
These  results suggest that  the  final  product of the reaction of 
enzyme with  TSC was PLP-thiosemicarbazone. 
Kinetics of Formation of Intermediates upon Interaction of 
the Enzyme  with TSC-The analysis of the  spectra  in Figs. 3 
and 4 suggested that  the  kinetics of the individual steps  in 
the  reaction could best be monitored by measuring  the  ab- 
sorbance  changes at  464,  440, 390, and 320 nm. The reaction 
was monitored at  each of these wavelengths under pseudo- 
first order conditions. The increase in absorbance was bi- 
phasic at  390 and 320 nm.  The calculated  second order  con- 
stants  from  the  first  order  plots was 11 "' s" at  464 and 440 
nm. The  faster  phase of increase in absorbance at  390 and 
320 nm followed pseudo-first order kinetics with a second 
order  rate  constants of 8 M" s-'. In  addition  to  this  step  there 
was a slow phase of decrease in  absorbance at  464 and 440 
nm  and  the slower phase of increase  in  absorbance at  390 and 
320 nm  with  the isosbestic point a t  411 nm. An approximate 
first  order  rate  constant for this reaction  was  calculated to be 
4 X s" by following the rate of decrease at  464 and 440 
nm for time periods  when the  absorbance  at  these wavelengths 
were about 20% of its original  amplitude. Measurements could 
not be taken beyond these time points because of the ex- 
tremely slow nature of this  transition,  and  the nzyme began 
to  denature. 
Interaction of TSC with PLP  and Ne-Acetyl-L-lysine-PLP 
Schiff Base-Upon the  addition of TSC (1 mM) to  PLP (100 
pM)  there was an  increase in absorbance at  390 and 320 nm 
indicating  the  formation of PLP-thiosemicarbazone  (data  not 
shown).  Upon  the  addition of TSC (1 mM) to  PLP-Ne-acetyl- 
L-lysine Schiff base, there was a decrease in absorbance at  
410 nm  associated with  a  blue shift slowly and a subsequent 
increase in absorbance a t  390 and 320 nm. This indicated 
that  TSC  interacted  with  the Schiff base  to form the  thiosem- 
icarbazone. 
DISCUSSION 
The  data  presented  in  this  paper clearly demonstrates  that 
the  time-dependent  inactivation of sheep liver SHMT by TSC 
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FIG. 8. Minimal kinetic mechanism for the interaction of 
TSC with sheep liver SHMT. E, holoenzyme; E',  apoenzyme; 
PLP. TSC, pyridoxal phosphate thiosemicarbazone. 
probably represents slow binding inhibition (Williams and 
Morrison, 1979; Morrison, 1982; Morrison  and  Walsh, 1987). 
The  onset of the reaction was very slow and could be moni- 
tored,  as in the case of the  inhibition of galactosidase by D- 
galactal (Wentworth and Wolfenden, 1974) using conven- 
tional  spectrophotometry.  The  results described in  this  paper 
are compatible with  the following minimal  kinetic  mechanism 
given  for the  interaction of TSC  with  the sheep liver SHMT 
in Fig. 8. 
The  first  step  in  the  interaction of TSC  with  sheep liver 
SHMT was slow and  had a second order  rate  constant of 11 
M" s" when absorbance change was monitored a t  440 and 
464 nm and 8 M" s" a t  390 and 320 nm. A similar rate 
constant was obtained for the  interaction of L-alanine phos- 
phonate with alanine racemase  from Thermophillus  stearoth- 
ermophillus (Badet et al., 1986). The  first  step  in  the  interac- 
tion was probably bifurcated  into two  pathways: one leading 
to  the  formation of E-TSCl  characterized by the  absorbance 
maxima at  464 and 440 nm and the other leading to the 
formation of apoenzyme and  PLP-thiosemicarbazone  absorb- 
ing  at 390 and 320 nm. The catalytically  active  enzyme upon 
interaction with TSC  under  pseudo-first  order  reaction con- 
ditions for 15 min  (the  time  taken  to form E-TSCl  as  in Fig. 
3 )  leads to a concentration-dependent  inhibition of enzyme 
activity.  From  the double reciprocal plots at varying serine 
concentrations  and  different fixed concentrations of TSC, a 
Kt of 50 PM was calculated. PLP partially reversed the  inhi- 
bition (Table I). This observation can be explained by the 
minimal  kinetic mechanism as due to  the  inability of E-TSCl 
to  be reversed by PLP.  The apoenzyme and  PLP-thiosemi- 
carbazone formed by the  alternative  pathway could be con- 
verted to catalytically active enzyme upon the addition of 
PLP. As there was a mixture of the two forms at this  point 
(15 min)  partial reversal by PLP was in accordance  with the 
mechanism.  The increased reactivation with time  upon  addi- 
tion of PLP was due  to  the slow conversion of E-TSCl  to  the 
apoenzyme. Morrison  and  Walsh (1987) classified  reversible 
inhibitors  as classical, tight  binding, slow binding, and slow 
tight binding. Tight  binding  inhibitors  are defined as  those 
which  produce substantial  inhibition  at  concentrations  that 
are comparable to  the  total enzyme concentration  in  the assay. 
Slow binding inhibitors are defined as those for which, a t  
concentrations that cause moderate inhibition, equilibrium 
between enzyme, inhibitor,  and  enzyme-inhibitor complex is 
not reached  before substantial depletion of the  substrate  has 
taken place. TSC could thus be regarded as a slow binding 
inhibitor of SHMT  resulting in the  generation of E-TSC1 at 
the active site of the enzyme and was probably  enzyme-bound. 
PLP  bound  to several  enzymes have been  shown to produce 
characteristic dichroic  signals  (Wilson and Meister, 1966; 
Martinez-Carrion et al., 1970; Bayley and  Harris, 1975; Miles 
and Moriguchi, 1977; Johnson  and Graves, 1966). SHMT also 
has a characteristic CD band at 430 nm  (Quashnock et al., 
1983; Manohar et al., 1982). Free PLP  and N"-acetyl-L-lysine- 
P L P  Schiff base exhibit  little CD rotations  in  this region. I t  
may be argued that  characteristic visible CD spectra  represent 
the presence of PLP  at  the active site of these enzymes. It 
may therefore be suggested that  the  E-TSC1 which showed 
dichroic bands  at 464 and 440 nm was present at  the active 
site,  and  the  subsequent very slow decrease in  the CD spec- 
trum at these wavelengths would indicate  that  this  interme- 
diate remained within the asymmetric milieu of the active 
site for long periods of time. Additional evidence that  this 
intermediate was enzyme-bound was the observation that 
upon  Centricon  filtration or upon passage of E-TSC1  through 
Sephadex G-25 gel-filtration column (data not shown), the 
protein fraction contained the 464- and 440-nm absorbing 
species.  Upon denaturation of the enzyme  by heating or with 
guanidinium hydrochloride (data  not  shown),  the  intermedi- 
ate was  rapidly converted  to  the  PLP-thiosemicarbazone. All 
attempts  to  obtain  the  intermediate free of the enzyme were 
unsuccessful. Intermediates  absorbing at longer  wavelengths 
have  been  observed upon  interaction of glycine and  H4-folate 
with  the enzyme and have  been  assigned a resonance-stabi- 
lized quinonoid structure  (Quashnock et al., 1983). In  the case 
of aspartate aminotransferase (Jenkins, 1961), tryptophan 
synthase (Miles, 1980), and SHMT (Schirch and Jenkins, 
1964a,  1964b) and several other  PLP enzymes, the  interaction 
with a variety of substrates  and  substrate analogues yielded 
intermediates  absorbing at  longer  wavelengths. These  inter- 
mediates  have been identified as resonance-stabilized semi- 
quinones. In analogy  with these observations, it  can be sug- 
gested that  E-TSC, could be a  resonance-stabilized  quinonoid 
form of PLP.  TSC  at   the enzyme-active  site. The presence of 
a thioketone group in  the  inhibitor seems to be essential for 
the formation of the presumed quinonoid intermediate as 
semicarbazide  does not yield such  an  intermediate  upon  in- 
teraction  with SHMT.' Such  an  unique  intermediate was not 
reported  in  the reaction of TSC  with  aspartate  aminotrans- 
ferase (Jenkins and D'Ari, 1966), glutamate decarboxylase 
(Fisher and Davies, 1974), 3,4-dihydroxyphenylalanine hy- 
droxylase, and  5-hydroxytryptophan decarboxylase (Slow and 
Dakshinamurti, 1990). 
This  intermediate dissociates to yield the holoenzyme with 
a calculated first-order  ate  constant (kOff) of 5 x s" 
measured by the  dilution of E-TSC1 complex and  monitoring 
the recovery of enzyme activity (Fig. 7, inset). The  next  step 
in  the  kinetic  mechanism is the conversion of E-TSC1  to  the 
apoenzyme ( E ' )  and  PLP-thiosemicarbazone.  This  step was 
measured by the decrease in  absorbance at 464 and 440 nm 
and  the slow phase of increase in  absorbance  at 390 and 320 
nm. This  reaction was extremely slow, and a 50% decrease  in 
absorbance occurred  in about 5-6 h. An approximate  rate  for 
this step was calculated to be about 4 X s-'. The absence 
of any  circular dichroic bands at 390 nm suggested that  the 
PLP-thiosemicarbazone was probably not  at  the active  site. 
The PLP-thiosemicarbazone could be separated from the 
enzyme protein by Centricon  filtration or gel filtration.  The 
apoenzyme thus  generated ( E ' )  could be partially  reactivated 
with  PLP. 
In a detailed  study  Jenkins  and D'Ari (1966) examined  the 
interaction of TSC with aspartate aminotransferase in the 
presence and absence of glutarate. In addition, they also 
examined  the effects of TSC  on  the  interaction of aminooxy 
compounds with aspartate aminotransferase (Raunio et al., 
1984). These  results  indicated  that  the  reaction of TSC  with 
the enzyme was slow, with a second order rate  constant of 
about 1 M" s" compared  to  about 10 M" s" observed in  this 
study.  It is pertinent  to  mention  that  in  the case of aspartate 
aminotransferase  the  pH at which the  rates were measured 
* J. K. Acharya and N. Appaji  Rao, unpublished observations. 
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was 6.9, and  in  the case of SHMT  i t  was 7.4 (pH values at 
which the reactions were optimal). The kOff in the case of 
aspartate  aminotransferase was about 8 x s-' compared 
to  5 X s-' for the initial phase of the reaction of TSC 
with  SHMT (Fig. 7). One  significant  difference, in  the  inter- 
action of TSC with the two enzymes, is the formation of 
longer  wavelength absorbing species in  the  interaction of TSC 
with SHMT. Although it was indicated that the complex 
absorbing at  390 nm, formed when TSC interacted with 
aspartate aminotransferase, was a mixture of two species, 
detailed  kinetic  analysis of the  formation of the complex was 
not  reported  (Sizer  and  Jenkins, 1962). The  product of the 
reaction in both  the cases  was  probably PLP-thiosemicarba- 
zone as  indicated by its  characteristic absorbance. 
Davies and  Johnston (1974), in  their  study  conducted  to 
correlate  the regional and developmental patterns of glycine 
levels in the postnatal rat brain reported the inhibition of 
SHMT from  cerebellar extract by TSC. No other  details of 
interaction of TSC  with  SHMT were discussed in  that  paper. 
Our  results  are compatible  with the suggestion that  TSC is a 
slow binding  inhibitor of SHMT  and  the slow-binding of TSC 
with  sheep liver SHMT results  in  the  formation, at the active 
site of SHMT, of a hitherto  undetected  intermediate  absorb- 
ing  at 464 and 440 nm. This  intermediate is converted  to  the 
PLP-thiosemicarbazone extremely slowly, highlighting the 
potential of these reactions in the design of effective and 
specific inhibitors for SHMT. 
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